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Objectives: The superiority of microdissec-
tion testicular sperm extraction (mTESE)
over conventional TESE (cTESE) for men with non-obstructive
azoospermia (NOA) is debated. We aimed to compare the
sperm retrieval rate (SRR) of mTESE to cTESE and to identify
candidates who would most benefit from mTESE in a cohort of
Caucasian-European men with primary couple’s infertility. 
Material and methods: Data from 49 mTESE and 96 cTESE
patients were analysed. We collected demographic and clinical
data, serum levels of LH, FSH and total testosterone. Patients
with abnormal karyotyping were excluded from analysis.
Age was categorized according to the median value of 35 years.
FSH values were dichotomized according to multiples of the
normal range (N) (N and 1.5 N: 1-18 mIU/mL, and > 18
mIU/mL). Testicular histology was recorded for each patient.
Descriptive statistics and logistic regression analyses tested the
impact of potential predictors on positive SRR in both groups. 
Results: No differences were found between groups in terms of
clinical and hormonal parameters with the exception of FSH
values that were higher in mTESE patients (p = 0.004). 
SRR were comparable between mTESE and cTESE (49.0% vs.
41.7%, p = 0.40). SRRs were significantly higher after mTESE
in patients with Sertoli cell-only syndrome (SCOS) (p = 0.038),
in those older than 35 years (p = 0.03) and with FSH > 1.5N
(p < 0.001), as compared to men submitted to cTESE.
Multivariable logistic regression analysis showed that mTESE
was independent predictor of positive SR in patients older than
35 years (p = 0.002) and with FSH > 1.5N (p = 0.018).
Moreover, increased FSH levels (p = 0.03) and both SCOS
(p = 0.01) and MA histology (p = 0.04) were independent pre-
dictors of SRR failure. 
Conclusions: Microdissection and cTESE showed comparable
success rates in our cohort of patients with NOA. mTESE
seems beneficial for patients older than 35 years, with high
FSH values, or when SCOS can be predicted. Given the high
costs associated with the mTESE approach, the identification
of candidates most likely to benefit from this procedure is a
major clinical need.
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INTRODUCTION
In contrast to obstructive azoospermia in which there is
an obstruction in the ductal system, non-obstructive
azoospermia (NOA) refers to the absence of spermatozoa
in semen analysis due to minimal or no production of
fully developed spermatozoa in the testicles. 
Approximately 1% of all men and 10% of infertile men
are affected by testicular failure as a result of NOA (1).
Testicular spermatozoa can be retrieved in some NOA
men even despite the absence of ejaculated spermatozoa
in their semen, from isolated foci of active spermatogen-
esis. The chance of fatherhood for the NOA patient has
changed dramatically in recent years following the intro-
duction of surgical sperm retrieval techniques, in partic-
ular conventional TESE (cTESE) and microdissection TESE
(mTESE). Until recently, cTESE represented the first-line
option to retrieve spermatozoa in NOA subjects for intra-
cytoplasmic sperm injection (ICSI) (2). However, since its
introduction in 1999, mTESE has continuously been
found to be associated with better sperm retrieval rates
(SRRs) and fewer complications compared to cTESE (3).
Direct vision with the operating microscope in mTESE is
of great advantage as larger, whitish tubules, presumably
containing more germ cells with active spermatogenesis,
can be identified. Indeed, as reported by various authors,
the rate of positive SRR differs significantly between the
two techniques, ranging from about 63% to 42% in
mTESE and from 16% to 45% in cTESE (4-6). Moreover,
cTESE can be undermined by potential surgical compli-
cations, which are virtually absent in the mTESE series
(7, 8). This should not be ignored given that a significant
number of azoospermic patients are typically affected by
secondary disturbances, such hypogonadism, for which
mTESE may allow for better preservation of the testicu-
lar tissue. On the contrary, other authors have failed to
find a significant superiority of mTESE over cTESE in
terms of SRRs (9, 10). Moreover, the overall positive
SRR, lower costs and high reproducibility of cTESE rep-
resent unique characteristics that should be taken into
account when counseling NOA infertile couples (10). 
Microdissection TESE, indeed, is a technically challeng-
DOI: 10.4081/aiua.2018.2.130
Maglia_Stesura Seveso  28/06/18  16:38  Pagina 130
131Archivio Italiano di Urologia e Andrologia 2018; 90, 2
Personalized treatment for infertile men
ing and expensive procedure that requires dedicated
equipment and specifically trained surgeons. 
Considering the different characteristic of each surgical
technique and the high heterogeneity in the current lit-
erature regarding which technique is superior, we believe
it to be of paramount importance to define which
patients could benefit most from a complex surgery such
as microdissectional TESE. The aim of the present study
is to compare SRR by mTESE with that obtained by con-
ventional TESE in NOA patients and to identify the
patients who could most benefit from a microsurgical
approach by finding the best predictors of positive sperm
retrieval in our cohort.
MATERIALS AND METHODS
The analyses of this cross-sectional study were based on a
sample of 145 consecutive white-European men assessed
at a single academic centre for primary couple’s infertility
(non-interracial infertile couples only) between January
2012 and April 2017. The initial cohort included 149
patients, however 4 (2.68%) men were excluded from the
final analysis for missing values. According to the World
Health Organisation (WHO) criteria, infertility was defined
as not conceiving a pregnancy after at least 12 months of
unprotected intercourse regardless of whether or not a
pregnancy ultimately occurred (11). Primary infertility is
defined as when a couple has never been able to conceive
(11). Infertile patients were enrolled if they were between
18 and 55 years of age and had only male factor infertility
(MFI); MFI was defined after a comprehensive gynecolog-
ical evaluation of the female partner. All patients were
diagnosed with NOA on the basis of a complete history,
physical examination, endocrine profile, and chromoso-
mal analysis before being scheduled for TESE with sperm
freezing. 
All patients underwent chromosomal analysis and those
with abnormal karyotyping were excluded from the
study cohort. Patients underwent at least two consecu-
tive semen analyses, both showing absence of spermato-
zoa in the ejaculate after centrifugation. Semen samples
were collected by masturbation and analysed within 2 h
according to the WHO criteria.
Patients were assessed with a thorough medical history
including age and comorbidities. Age was categorized
according to the median value of 35 yrs. Comorbidities
were scored with the Charlson Comorbidity Index (CCI)
(12). We used the International Classification of Diseases, 9th
revision. For the specific purpose of the analysis, CCI was
categorized as 0 or ≥ 1. All individuals were sexually active,
reporting to have intercourse at least four times per month.
Body mass index (BMI) defined as weight in kilograms by
height in square meters, was calculated. BMI was consid-
ered using the cut offs proposed by the National Institutes of
Health (NIH): normal weight (18.5-24.9), overweight
(25.0-29.9), and class ≥ 1 obesity (≥ 30.0). Lifestyle factors
potentially related with any impairment of semen quality
were carefully assessed. Colour-Doppler ultrasound was
used to detect spermatic vein reflux and to classify the
grade of varicocele in infertile patients. As a main entry cri-
terion for the study, only patients with complete data col-
lection were included; therefore, patients with incomplete
medical history were excluded. Venous blood samples were
drawn from each infertile patient between 7 AM and 11
AM after an overnight fast. Follicle-stimulating hormone
(FSH), luteinising hormone (LH) and prolactin (PRL) were
measured using a heterogeneous competitive magnetic sep-
aration assay (Bayer Immuno 1 System, Bayer Corp.,
Tarrytown, NY, USA). Total testosterone (tT) levels were
measured via a direct chemiluminescence immunoassay
(ADVIA Centaur; Siemens Medical Solutions Diagnostics,
Deerfield, IL, USA). Hypogonadism was defined as tT less
than 3 ng/ml (13). The same laboratory analyzed all param-
eters for all patients. FSH values were categorized into two
groups according to multiples of the normal range (N) (N
and 1.5N: 1-18 mIU/mL, and > 18 mIU/mL). 
Patients included in the study were scheduled for conven-
tional cTESE or mTESE based on the availability of the
surgical waiting list. Informed consent was obtained after
a thorough explanation of results in the literature and the
invasiveness of the surgical technique. Testicular histology
was recorded based on the predominant histological pat-
tern, such as hypospermatogenesis (HS), maturation arrest
(MA) and Sertoli cell-only syndrome (SCOS). The same
pathologist reviewed all the tissue samples.
Conventional TESE was performed, under general or
local anesthesia, unilaterally on the larger testis; when
testes volume was equal, the right testis was used.
Through a small horizontal incision in the right-median
part of the scrotal, the skin, dartos muscle, and tunica
vaginalis were opened to expose the tunica albuginea.
The tunica albuginea was incised for about 5 mm at the
middle of the testis. Multiple testicular specimens were
excised and dispersed between two glass slides, and the
embryologist observed the samples under the optic
microscope. If no sperm were seen in the initial sample,
subsequent samples were taken from other locations, in
the upper and lower pole of the testis, and subsequently
from the contralateral testis (in only 12% of the cases). 
Microdissection TESE was performed under general
anesthesia according to the procedure reported previous-
ly (3). An attempt was made to identify individual semi-
niferous tubules that were larger, more opaque and
whiter than other tubules in the testicular parenchyma,
which were considered to likely contain spermatozoa. If
all tubules were seen to have an identical morphological
appearance, at least three samples (upper, middle, and
lower) were obtained. If no sperm were obtained from
the initial sample, the same procedure was performed in
the contralateral testis (in 20% of the cases). At the same
time of testicular intervention in both procedures, a
small tissue specimen was placed in Bouin’s solution and
sent for histopathological examination.
Data collection was carried out following the principles
outlined in the Declaration of Helsinki; after approval of
the IRCCS Fondazione Ca’ Granda Ospedale Maggiore
Policlinico Ethical Committee, all patients signed an
informed consent agreeing to supply their own anony-
mous data for this and future studies.
Data are presented as means (SD; ranges). The statistical
significance of differences in means and proportions was
tested with the one-way analysis of variance (ANOVA) and
Pearson chi-square test, respectively. A 95% confidence
interval was estimated for the association of categorical
Maglia_Stesura Seveso  28/06/18  16:39  Pagina 131
Archivio Italiano di Urologia e Andrologia 2018; 90, 2
E. Maglia, L. Boeri, M. Fontana, A. Gallioli, E. De Lorenzis, F. Palmisano, S.P. Zanetti, G. Sampogna, L. Restelli, E. Somigliana, M. Serrago, F. Gadda, E. Montanari
132
parameters. Exploratory analyses were initially applied to
all variables; variables were retained for analysis when
deemed clinically significant to the results. Descriptive sta-
tistics tested the association between clinical and hormon-
al variables and the sperm retrieval rate according to the
surgical technique. Logistic regression univariable analysis
(UVA) and multivariable analysis (MVA) tested the associa-
tions between clinical and laboratory predictors and
sperm retrieval failure. Moreover, logistic regression analy-
ses tested the association between clinical predictors (e.g
age, FSH, testicular histology and surgical technique)
and positive sperm retrieval in patients older than the
median value of 35 years and in those with FSH > 1.5N
(18 mUI/mL). Statistical tests were performed using SPSS
v. 19 (IBM Corp., Armonk, NY, USA). 
All tests were two sided, with a signifi-
cance level set at 0.05. 
RESULTS
Table 1 lists the characteristics and the
descriptive statistics of the entire cohort
of individuals. Overall, 96 (66.2%) and
49 (33.8%) infertile patients were sub-
mitted to cTESE and mTESE, respective-
ly. The two groups did not differ in
terms of age, BMI and CCI. There were
no differences in terms of lifestyle fac-
tors, history of cryptorchidism, presence
of varicocele and postoperative compli-
cations between groups. Histologic
reports showed hypospermatogenesis,
maturation arrest and Sertoli cell-only
syndrome in 49 (33.7%), 32 (22%) and
64 (44.1%) patients, respectively, with
no difference according to the surgical
technique. The success rate of sperm
retrieval in patients with NOA was com-
parable between mTESE and cTESE
(49.0% vs. 41.7%, p = 0.40).
Table 2 depicts the hormonal character-
istics of infertile patients according to
the surgical technique. No differences
were found between groups in terms of
hormonal parameters with the excep-
tion of FSH values that were higher in
mTESE patients (20.9 vs. 12.8 mUI/ml;
p = 0.004).
Table 3 shows the influence of clinical
parameters (age, FSH values and histo-
logical reports) on the success rate of
sperm retrieval between groups. Sperm
retrieval rate was positive in 22/61
(36.1%) patients with FSH ≥ 1.5N (18
mIU/mL) (18/30 with mTESE, 4/31 with
cTESE) and in 42/84 (50.0%) patients
with FSH < 1.5N (6/19 with mTESE,
36/65 with cTESE). mTESE resulted in a
higher SRR for those with FSH ≥ 1.5N
(p = 0.001). Age had a significant impact
on sperm retrieval rate in the two
groups. In patients younger than 35
years, SRR was positive in 48.9% and
41.6% of men submitted to cTESE and
mTESE, respectively. However, for those
older than 35 years, mTESE resulted in a
significantly higher SRR (56.0% vs.
35.0%, p = 0.03). The influence of his-
tological diagnosis on the success rate of
Table 1. 
Characteristics and descriptive statistics of patients (No. = 145).
Overall cTESE mTESE P value (F)*
No. of patients [No. (%)] 145 (100) 96 (66.2) 49 (33.8)
Age (years) 0.55 (0.34)
Mean (SD) 35.4 (5.4) 35.6 (5.4) 34.9 (5.5)
Range 21-54 21-54 23-48
Categorized age [No. (%)] 0.82 (χ2, 0.9)
50-60 3 (2.1) 2 (2.6) 1 (2.9)
61-70 73 (50.3) 48 (50.0) 25 (50.0)
71-80 67 (46.2) 44 (44.9) 23 (47.1)
≥ 81 2 (1.4) 2 (2.6) 0 (0.0)
BMI (kg/m2) 0.07 (4.09)
Mean (SD) 26.8 (3.4) 26.2 (3.1) 29.0 (3.7)
Range 19.0-34.9 19.0-31.1 24.1-34.9
Categorized BMI [No. (%)] 0.36 (χ2, 2.00)
18.5-24.9 39 (26.8) 32 (33.3) 7 (14.3)
25-29.9 83 (57.2) 55 (57.1) 28 (57.1)
≥ 30 23 (15.8) 9 (9.5) 14 (28.6)
CCI [No. (%)] 0.74 (χ2, 0.11)
CCI 0 110 (75.8) 75 (77.8) 35 (72.7)
CCI ≥ 1 35 (24.1) 21 (22.2) 14 (27.3)
Current Smokers [No. (%)] 35 (24.1) 21 (22.2) 14 (27.3) 0.72 (χ2, 0.13)
Varicocele [No. (%)] 52 (35.8) 35 (36.5) 17 (34.6) 0.86 (χ2, 0.31)
Cryptorchidism [No. (%)] 27 (18.6) 22 (23.2) 5 (9.1) 0.15 (χ2, 2.1)
Positive SRR [No. (%)] 64 (44.1) 40 (41.7) 24 (49.0) 0.40 (χ2, 0.70)
Histologic reports [No. (%)] 0.30 (χ2, 2.39)
Hypospermatogenesis 49 (33.7) 28 (28.9) 21 (42.6)
Maturation arrest 32 (22.0) 23 (23.7) 9 (19.1)
Sertoli cell-only syndrome 64 (44.1) 45 (47.4) 19 (38.3)
Postop. complications [No. (%)] 3 (2.0) 2 (2.1) 1 (2.0) 0.43 (χ2, 1.04)
BMI = body mass index; CCI = Charlson Comorbidity Index; SRR = Sperm retrieval rate; 
*P value according to chi-square test or analysis of variance (ANOVA), as indicated.
Table 2. 
Hormonal characteristics of patients (No. = 145).
Overall cTESE mTESE P value (F)*
FSH (mUI/mL) 0.04 (8.89)
Mean (SD) 14.8 (11.8) 12.8 (11.1) 20.9 (12.1)
Range 1.71-59 1.71-52.3 1.81-59
LH (mUI/mL) 0.15 (2.12)
Mean (SD) 5.7 (4.3) 5.3 (4.1) 7.2 (4.9)
Range 1.91-18.5 1.91-18.5 2.55-17.7
tT (ng/mL) 0.12 (2.36)
Mean (SD) 5.0 (4.1) 5.4 (4.5) 3.6 (1.7)
Range 1.17-24.1 1.17-24.1 2.16-7.58
tT < 3 ng/mL [No. (%)] 34 (23.4) 18 (19.2) 16 (33.3) 0.25 (χ2, 1.33)
PRL (ng/mL) 0.54 (0.36)
Mean (SD) 26.3 (9.2) 30.1 (10.6) 11.7 (6.44)
Range 4.6-68.1 4.6-68.1 5.0-26
tT = Total Testosterone; FSH = Follicle-stimulating hormone; LH = Luteinising hormone; PRL = prolactin. 
*P value according to chi-square test or analysis of variance (ANOVA), as indicated.
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sperm retrieval was also considered. We obtained sperma-
tozoa via cTESE in 64.2% and via mTESE in 55.0% of
men with a histological diagnosis of hypospermatogenesis.
In case of MA, we retrieved sperm in 34.7% of patients via
cTESE and in 33.3% via mTESE. For those with SCOS,
mTESE produced a significantly higher SRR (50.0% vs.
31.1% with cTESE, p = 0.03). In order to strengthen the
association between mTESE and positive
sperm retrieval in older men and in those
with higher FSH levels we conducted a
logistic regression analysis assessing the
relationship between clinical predictors
(e.g age, FSH, testicular histology and
surgical technique) and positive sperm
retrieval in the two groups (Table 4). In
patients older than the median value of
35 years mTESE was univariably associ-
ated with positive SR (p = 0.04) and
emerged as the only independent predic-
tor of positive SR (OR 7.22; p = 0.002)
after adjusting for FSH values and testic-
ular histology. Similarly, in men with FSH
> 18 mUI/mL, mTESE was associated
with positive SRR (p = 0.001) at UVA and
showed independent predictor status for
positive SR (OR 9.52; p = 0.018) at MVA,
after adjusting for age and testicular his-
tology.
Table 5 details UVA and MVA logistic
regression models testing the associa-
tions between predictors and sperm
retrieval failure. UVA showed that high-
er FSH (p = 0.008), a histological report
of SCOS (p = 0.014) and MA (p = 0.04)
were associated with negative SRR.
Conversely, age, LH and testosterone
values were not. Similarly, logistic MVA
revealed that FSH levels (OR 1.3, p =
0.03), histological reports of SCOS (OR
2.17, p = 0.01) and MA (OR 1.87, p =
0.04) achieved independent predictor
status for sperm retrieval failure.
DISCUSSION
This study was conducted to evaluate
potential differences in terms of SRRs
between mTESE and cTESE in our
cohort of NOA men, and to determine
which patients could most benefit from
each procedure. We found that mTESE
yields overall greater, albeit not signifi-
cantly, rates of sperm retrieval than
cTESE. Secondly, we noted that mTESE
lead to a higher SRR than cTESE in
older patients (> 35 years), in patients
with elevated FSH (i.e > 18 mUI/ml)
and in those with a histological diagno-
sis of SCOS. mTESE emerged as inde-
pendent predictor of positive SR in
patients older than 35 years and in
those with FSH >18 mUI/mL. 
Moreover, the most reliable predictors of negative sperm
retrieval were elevated FSH and both SCOS and MA his-
tology. 
This study was prompted by existing controversies in the
scientific literature regarding the role of mTESE and
cTESE as treatment options for azoospermic men. In
fact, determining which of the two procedures is more
Table 3. 
Sperm retrieval rate according to the class of FSH values, 
age and histologic reports.
cTESE mTESE P value (F)*
FSH (mUI/mL)
< 18 36/65 (55.3%) 6/19 (31.5%) 0.66 (0.18)
> 18 4/31 (12.9%) 18/30 (60.0%) 0.001 (7.0)
Age (years)
< 35 23/47 (48.9%) 10/24 (41.6%) 0.67 (0.18)
> 35 17/49 (35.0%) 14/25 (56.0%) 0.03 (4.27)
Histologic reports
Hypospermatogenesis 18/28 (64.2%) 12/21 (55.0%) 0.77 (0.01)
Maturation arrest 8/23 (34.7%) 3/9 (33.3%) 0.76 (0.09)
Sertoli cell-only syndrome 14/45 (31.1%) 9/19 (50.0%) 0.03 (4.29)
*P value according to chi-square test analysis.
Table 4. 
Logistic regression models predicting positive sperm retrieval 
(OR; p value [95%CI]) in patients with age > 35 years and FSH > 18 mUI/mL.
Positive sperm retrieval
Age > 35 years FSH > 18 mUI/mL
UVA model MVA model UVA model MVA model
cTESE vs. mTESE 13.40; 0.04 7.22; 0.002 12.66; 0.001 9.52; 0.018
(1.41-21.17) (2.01-15.82) (2.49-24.22) (1.96-19.26)
Age - - 0.23; 0.76 0.11; 0.18
(0.11-1.15) (0.06-1.89)
FSH 0.97; 0.10 0.18; 0.90 - -
(0.88-1.02) (0.05-1.17)
Histologic report
Hypospermatogenesis Ref. Ref. Ref. Ref.
Sertoli cell-only syndrome 0.21; 0.12 0.12; 0.24 0.20; 0.11 0.31; 0.78
(0.02-1.52) (0.03-4.31) (0.03-1.43) (0.21-1.63)
Maturation arrest 0.34; 0.19 0.11; 0.21 0.23; 0.11 0.34; 0.78
(0.06-1.74) (0.05-3.40) (0.04-1.35) (0.20 -1.45)
UVA = Univariate model; MVA = Multivariate model.
Table 5. 
Logistic regression models predicting negative sperm retrieval 
(OR; p value [95% CI]) in the whole cohort (n = 145).
Sperm retrieval failure
UVA model MVA model
OR (95% CI) P value OR (95% CI) P value
Age 1.04 (0.95- 1.13) 0.38 1.13 (0.83-1.55) 0.41
FSH 1.11 (1.02-1.16) 0.008 1.31 (1.01-1.68) 0.03
LH 0.76 (0.91-1.21) 0.46 0.65 (0.89-1.26) 0.07
Testosterone 0.96 (0.92-1.22) 0.40 0.98 (0.79-1.21) 0.87
Histologic report
Hypospermatogenesis Ref. Ref.
Sertoli cell-only syndrome 4.21 (1.31-3.32) 0.014 2.17 (1.01-8.87) 0.01
Maturation arrest 3.20 (1.16-1.32) 0.04 1.87 (1.02-7.52) 0.04
UVA = Univariate model; MVA = Multivariate model.
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likely to produce a better outcome remains challenging
since, to date, a general consensus is still lacking among
the different authors. 
In terms of SRR, the current literature reports quite unani-
mously a superiority of mTESE over conventional TESE (4-
6, 9, 14). For instance, Okada et al. (4) reported a SRR of
16.7% for the cTESE group and 44.6% for mTESE. More
recently Ghalayini et al. (6) found that sperm retrieval was
successful in 56.9% patients undergoing mTESE in com-
parison with only 38.2% of cTESE patients. The present
study showed a slight, but not statistically significant, supe-
riority of mTESE over cTESE in terms of SRR (49.0% vs
41.7%). Other authors have also shown a superiority of
mTESE over cTESE in terms of overall SRR but without a
statistically significant difference between groups (15). 
Previous studies found conventional TESE to be associ-
ated with significantly higher complication rates than
mTESE (4, 7). Acute and chronic ultrasonographic
abnormalities such as haematoma, loss of testicular tis-
sue, inflammatory changes and permanent devasculari-
sation may be found after cTESE (7). Moreover, cTESE
may be associated with higher rates of wound infection
and iatrogenic hypogonadism that mTESE (4). We did
not find any differences between groups in terms of post-
operative complications, probably due to the low rate of
adverse events in our cohort (3 patients, 2 with heam-
tomas and 1 with wound infections). 
Conventional TESE could still offer some advantages
over mTESE. Firstly, microsurgical training generally
represents a lengthy, expensive and demanding process
that likely cannot be sustained in every institution. In
fact, Ishikawa et al. (15) showed a steeper learning curve
for mTESE compared with cTESE, highlighting a posi-
tive correlation between surgical outcomes and turnover
of mTESE operations. Secondly, mTESE requires dedi-
cated and expensive equipment (especially an operating
microscope) as well as longer operative times. It is there-
fore difficult to find a compromise that guarantees the
best quality at the lowest cost. One way to deal with this
issue could be tailor patient treatment based on robust
predictive factors for positive SRR. To date, many prom-
ising candidates for predictors have been proposed, but
a general consensus is still lacking. 
Testicular volume is amongst the frequently proposed
predictors. However, Colpi et al. (14) and Ghalayini et al.
(6) found contrasting results, with the former showing
no correlation and the latter a positive correlation
between higher testicular volume and SRRs. 
Another factor, advanced age, is generally associated
with poorer sperm parameters and reproductive out-
comes (16). However, recent studies have shown that age
may not adversely affect sperm retrieval in men under-
going TESE (10, 17). Of clinical importance, we found
significantly higher SRRs with mTESE in patients older
than the median value of 35 years when compared to
aged-match patients undergoing cTESE. Moreover,
mTESE was an independent predictor of positive SR in
men older than 35 years after adjusting for FSH values
and testicular histology. This finding could provide an
easy to obtain and reliable predictor for identifying the
best candidates to submit to mTESE, especially if they
belong to poor prognosis groups. 
Serum hormonal values represent another potentially
useful predictor of SRRs. Colpi et al. (14) and Ghalayini et
al. (6) reported a higher failure in sperm retrieval among
patients with increased FSH levels. Conversely,
Ramasamy et al. (18) observed comparable or better
results in men with high FSH in terms of microsurgical
retrieval. Our study strongly supports the negative asso-
ciation between SRR and FSH levels as we found FSH to
be an independent predictor of SR failure in the overall
cohort of patients and, more importantly, we showed
that SRR was significantly higher in mTESE patients with
high FSH when compared with cTESE patients with
comparable hormonal values. To strengthen this finding
we performed a multivariable analysis to predict positive
SRR in men with higher FSH values and we found that
mTESE was independent predictor of positive SR after
adjusting for age and testicular histology.
Testicular histological pattern is one of the most promis-
ing parameters for providing both the clinician and
patient with a reliable and robust predictive tool for SR
outcomes. Unfortunately, and differently from the other
aforementioned factors, it can be provided only through
an invasive surgical procedure and is, therefore, mainly
evaluated intraoperatively or retrospectively. 
Our data showed that SCOS patients had significantly
higher SRRs from mTESE compared to cTESE. Moreover,
SCOS and MA were independent predictors of SR failure.
Our outcomes are consistent with previous studies
showing the superiority of mTESE over cTESE in SR out-
comes for SCOS men (4, 6). 
Similarly, the significant association between both SCOS
and MA and sperm retrieval failure has been previously
reported (6, 19). It can be concluded that progressively
worse histological patterns are associated with lower
retrieval results. We can therefore speculate that
improvements in SRR in poor prognosis patients (those
with older age, high FSH values and SCOS) could be
achieved performing mTESE instead of cTESE. 
Our study presents some limitations. First, it is not a ran-
domized controlled study; our patients were assigned to
one of the two groups on the basis of the operating theatre
waiting list. Second, we didn’t consider some variables
such as inhibin B, Johnsen score and testicular volume,
which have been shown to have a relevant albeit contro-
versial predictive value. Finally, we were unable evaluate
the pregnancy rate associated with ICSI procedures follow-
ing sperm retrievals. Clinical pregnancy followed by the
delivery of a healthy child is the main goal of all the proce-
dures described, but it requires extensive follow up.
Nevertheless, our findings offer some positive implications
that could be useful to clinicians not only to offer realistic
counselling to couples undergoing ARTs treatments but
also to tailor the best treatment to the patient who could
most benefit from it. For example, we showed that mTESE
was associated with a better SRR than cTESE in older
patients. This finding is important in light of the fact that
advanced age is associated with decreasing testosterone lev-
els and mTESE guarantees better preservation of the testic-
ular tissue. Thus, with mTESE representing a reduced risk
of hypogonadism, the higher sperm retrieval rate would
make mTESE doubly beneficial for the patient. Secondly,
we confirmed the high predictive value of histology, espe-
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cially for cases of poor prognosis (SCOS and MA), with
mTESE yielding the best results for SCOS patients. A pre-
operative histological diagnosis is however difficult to
obtain unless the patient has already undergone a sperm
retrieval procedure. A proposed alternative could be a step-
wise approach, such as that described by Franco et al. (20),
which gradually increases surgical complexity only when
necessary. It is undeniable, however, that patients with
poor prognosis, as defined by histology, would greatly ben-
efit from moving directly to a microsurgical approach and
avoiding procedures that are extremely unlikely to produce
positive results.
CONCLUSIONS
In conclusion, microdissection and conventional TESE
showed comparable success rates for sperm retrieval in
our cohort of patients with NOA. mTESE seems to be
beneficial for patients older than 35 years, in patients
with high FSH values, or when SCOS can be predicted.
Given the high costs associated with the mTESE
approach, the identification of candidates most likely to
benefit from this procedure is a major clinical need. 
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